Bilexa Inhalation Capsule is a fixed-dose combination inhalation therapy containing Vilanterol Trifenatate (25 mcg) and Fluticasone Furoate (200 mcg). It is formulated for the long-term management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) where both bronchodilation and anti-inflammatory action are required. This combination works synergistically to improve lung function, control symptoms, and reduce the frequency of exacerbations.

Vilanterol Trifenatate is a long-acting beta₂-agonist (LABA) that helps relax airway smooth muscles, leading to prolonged bronchodilation and improved airflow. Fluticasone Furoate is a potent inhaled corticosteroid that reduces airway inflammation, swelling, and mucus production. Together, they provide effective, sustained control of respiratory symptoms and improve overall breathing comfort.

Bilexa Inhalation Capsule is intended for use with a compatible inhalation device and is suitable for regular maintenance therapy rather than acute symptom relief.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Benefits

Dual Mechanism for Better Control

• Combines a long-acting bronchodilator with an inhaled corticosteroid.

• Addresses both airway constriction and underlying inflammation.

Improves Lung Function

• Helps keep airways open for an extended period.

• Improves breathing capacity and reduces shortness of breath.

Reduces Exacerbations

• Regular use helps lower the risk of asthma attacks and COPD flare-ups.

• Supports long-term disease control and stability.

Controls Inflammation

• Fluticasone furoate helps reduce airway swelling and irritation.

• Decreases mucus production, leading to clearer airways.

Once-Daily Convenience

• Long duration of action allows for once-daily dosing.

• Improves patient compliance with maintenance therapy.

Indications

Bilexa Inhalation Capsule is indicated for:

• Maintenance treatment of asthma in patients requiring combination therapy.

• Long-term management of COPD, including chronic bronchitis and emphysema.

• Patients with persistent respiratory symptoms not adequately controlled with single-agent therapy.

Dosage & Administration

Use Bilexa Inhalation Capsule exactly as prescribed by a physician. The capsule is for inhalation use only and should not be swallowed. It must be used with a suitable dry powder inhaler device. Regular daily use is essential for optimal benefit, even when symptoms are well controlled.

Patients are advised to rinse their mouth with water after inhalation to reduce the risk of oral irritation.

Safety & Precautions

• Not intended for the relief of acute bronchospasm or sudden asthma attacks.

• Use with caution in patients with cardiovascular disorders, infections, or hypersensitivity to corticosteroids.

• Do not exceed the prescribed dose.

• Consult a healthcare professional before use if pregnant or breastfeeding.

• Store in a cool, dry place away from moisture and direct sunlight.

• Keep out of reach of children.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Why Choose Bilexa Inhalation Capsule?

Bilexa Inhalation Capsule offers effective and sustained respiratory control through its proven combination of Vilanterol Trifenatate and Fluticasone Furoate. Its dual-action approach helps improve breathing, reduce inflammation, and enhance quality of life for patients with chronic respiratory diseases. With convenient once-daily dosing, it supports better treatment adherence and long-term respiratory health.